The protective effects of ω-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats

Toxicology and Industrial Health

Volumn 31, Issue 7, 2015, Pages 638-644

  Tulubas, Feti ^a   Gurel, Ahmet ^a   Oran, Mustafa ^a   Topcu, Birol ^a   Caglar, Veli ^a   Uygur, Emine ^a  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Doxorubicin; kidney; liver; oxidative stress; 3 fatty acids

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OMEGA 3 FATTY ACID; SUPEROXIDE DISMUTASE; FISH OIL;

ANIMAL; ANIMAL EUTHANASIA; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; KIDNEY; LIVER; MALE; OXIDATIVE STRESS; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENERAL ANESTHESIA; KIDNEY PARENCHYMA; LIVER PROTECTION; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; RENAL PROTECTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; EUTHANASIA, ANIMAL; FATTY ACIDS, OMEGA-3; GLUTATHIONE; GLUTATHIONE PEROXIDASE; KIDNEY; LIVER; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 84936966955     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233713483203     Document Type: Article

References (45)

1. Al-Gayyar MM, Shams ME, Barakat EA (2012) Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. Pharmaceutical Biology 50: 297–303.
2. Azambuja E, Fleck JF, Batista RG et al. (2005) Bleomycin lung toxicity: who are the patients with increased risk? Pulmonary Pharmacology and Therapeutics 18: 363–366.
3. Baydas G, Yilmaz O, Celik S et al. (2002) Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Archives of Medical Research 33: 515–519.
4. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine 61: 882–888.
5. Bouzidi N, Mekki K, Boukaddoum A et al. (2010) Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. Journal of Renal Nutrition 20: 321–328.
6. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods in Enzymology 52: 302–310.
7. Bulucu F, Ocal R, Karadurmus N et al. (2009) Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity. Biological Trace Element Research 132: 184–196.
8. Burns CP, North JA (1986) Adriamycin transport and sensitivity in fatty acid-modified leukemia cells. Biochimica et Biophysica Acta 888: 10–17.
9. Burns CP, Spector AA (1994) Biochemical effects of lipids on cancer therapy. Journal of Nutritional Biochemistry 5: 114–123.
10. Chautan M, Calaf R, Leonardi J et al. (1990) Inverse modifications of heart and liver alpha-tocopherol status by various dietary n−6/n−3 polyunsaturated fatty acid ratios. Journal of Lipid Research 31: 2201–2208.
11. Deepa PR, Varalakshmi P (2005) Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment. Chemico-Biological Interactions 156: 93–100.
12. Demoz A, Willumsen N, Berge RK (1992) Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids 27: 968–971.
13. El-Mesery M, Al-Gayyar M, Salem H et al. (2009) Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Division 4: 6.
14. Fadillioglu E, Erdogan H, Sogut S et al. (2003) Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. Journal of Applied Toxicology 23: 71–74.
15. Grimm H, Mertes N, Goeters C et al. (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. European Journal of Nutrition 45: 55–60.
16. 24 via suppression of oxidative stress. Pharmacological Reports 60: 742–749.
17. Iraz M, Erdogan H, Ozyurt B et al. (2005) Brief communication: omega-3 essential fatty acid supplementation and erythrocyte oxidant/antioxidant status in rats. Annals of Clinical and Laboratory Science 35: 169–173.
18. Kalaiselvi P, Pragasam V, Chinnikrishnan S et al. (2005) Counteracting adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E. Clinical Chemistry and Laboratory Medicine 43: 834–840.
19. Kalender Y, Yel M, Kalender S (2005) Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology 209: 39–45.
20. Kansal S, Negi AK, Kaur R et al. (2011) Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(alpha)anthracene-induced mammary carcinogenesis. Tumour Biology 32: 167–177.
21. Khan MW, Priyamvada S, Khan SA et al. (2012a) Protective effect of omega-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside-induced nephrotoxicity and oxidative damage in rat kidney. Human and Experimental Toxicology 31: 1035–1049.
22. Khan MW, Priyamvada S, Khan SA et al. (2012b) Protective effect of omega-3 polyunsaturated fatty acids on l-arginine-induced nephrotoxicity and oxidative damage in rat kidney. Human and Experimental Toxicology 31: 1022–1034.
23. Koller M, Senkal M, Kemen M et al. (2003) Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clinical Nutrition 22: 59–64.
24. Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochemical and Biophysical Research Communications 71: 952–958.
25. Liang B, Wang S, Ye YJ et al. (2008) Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World Journal of Gastroenterology 14: 2434–2439.
26. Liu LL, Li QX, Xia L et al. (2007) Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats. Toxicology 231: 81–90.
27. Manoury B, Nenan S, Leclerc O et al. (2005) The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respiratory Research 6: 11.
28. Masters C (1996) Omega-3 fatty acids and the peroxisome. Molecular and Cellular Biochemistry 165: 83–93.
29. Melo JU, Santos JM, Kimura Ode S et al. (2010) Effects of fatty acids on liver regeneration in rats. Revista do Collegio Brasileiro de Cirurgioes 37: 351–357.
30. Mimnaugh EG, Trush MA, Gram TE (1986) A possible role for membrane lipid peroxidation in anthracycline nephrotoxicity. Biochemical Pharmacology 35: 4327–4335.
31. Mylroie AA, Collins H, Umbles C et al. (1986) Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicology and Applied Pharmacology 82: 512–520.
32. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.
33. Prahalathan C, Selvakumar E, Varalakshmi P (2005) Protective effect of lipoic acid on adriamycin-induced testicular toxicity. Clinica Chimica Acta 360: 160–166.
34. Pritsos CA, Ma J (2000) Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity. Chemico Biological Interactions 127: 1–11.
35. Priyamvada S, Khan SA, Khan MW et al. (2010) Studies on the protective effect of dietary fish oil on uranyl-nitrate-induced nephrotoxicity and oxidative damage in rat kidney. Prostaglandins Leukot Essent Fatty Acids 82: 35–44.
36. Saad SY, Najjar TA, Al-Rikabi AC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacological Research 43: 211–218.
37. Schauder P, Rohn U, Schafer G et al. (2002) Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. British Journal of Nutrition 87(Suppl 1): S103–S110.
38. Singal PK, Iliskovic N, Li T et al. (1997) Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB Journal 11: 931–936.
39. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Advances in Food and Nutrition Research 65: 211–222.
40. Smith PK, Krohn RI, Hermanson GT et al. (1985) Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150: 76–85.
41. Stehbens WE (2003) Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Experimental and Molecular Pathology 75: 265–276.
42. Takayama F, Nakamoto K, Totani N et al. (2010) Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Journal of Oleo Science 59: 407–414.
43. Taneda S, Honda K, Tomidokoro K et al. (2010) Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. American Journal of Physiology Renal Physiology 299: F1451–F1461.
44. Weiss G, Meyer F, Matthies B et al. (2002) Immunomodulation by perioperative administration of n-3 fatty acids. British Journal of Nutrition 87(Suppl 1): S89–S94.
45. Yeh YC, Lai HC, Ting CT et al. (2007) Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochemical Pharmacology 74: 969–980.